Fundz

AbolerIS Pharma Appoints Philippe Alen as Chief Business Officer

PRIVATEOct 30, 2025

Position

Chief Business Officer

Company

AbolerIS Pharma

Philippe Alen
philippe.alen@aboleris-pharma.com
GosseliesBiotechnologyHealth Careresearch

Description

AbolerIS Pharma has announced the appointment of Philippe Alen as Chief Business Officer. Philippe will focus on driving strategic partnerships and corporate growth initiatives within the company.

Quick answer

AbolerIS Pharma Appoints Philippe Alen as Chief Business Officer (October 30, 2025). AbolerIS Pharma is based in Gosselies, Hainaut, Belgium.

Who is the new Chief Business Officer at AbolerIS Pharma?
AbolerIS Pharma named Philippe Alen Chief Business Officer, announced October 30, 2025.
What did AbolerIS Pharma announce on October 30, 2025?
AbolerIS Pharma has announced the appointment of Philippe Alen as Chief Business Officer. Philippe will focus on driving strategic partnerships and corporate growth initiatives within the company.
What does AbolerIS Pharma do?
AbolerIS Pharma is a clinical-stage biopharmaceutical company committed to improving the lives of patients suffering from autoimmune and inflammatory diseases.
Where is AbolerIS Pharma based?
AbolerIS Pharma is based in Gosselies, Hainaut, Belgium.
Which similar companies made leadership changes around the same time?
Van Andel Institute (October 30, 2025), Draig Therapeutics (November 3, 2025), Syndeio Biosciences (November 4, 2025) and Target RWE (November 4, 2025) also announced leadership changes within 45 days of AbolerIS Pharma.

Source: Fundz verified event record.

Other recent leadership changes in research and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at AbolerIS Pharma, and when

A new leader at AbolerIS Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day AbolerIS Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AbolerIS Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AbolerIS Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AbolerIS Pharma

Location

48 Rue Auguste Piccard

Gosselies, Hainaut, Belgium

About

AbolerIS Pharma is a clinical-stage biopharmaceutical company committed to improving the lives of patients suffering from autoimmune and inflammatory diseases. The Company is advancing potentially best-in-class and first-in-class immunomodulatory antibodies that target CD45RC, a key regulator of the immune system. AbolerIS' lead program, ABO21009, is designed to demonstrate broad efficacy in multiple autoimmune and inflammatory disorders with large unmet medical needs including rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and organ transplantation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AbolerIS Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Philippe
Likely contact at this company
••••••••@••••••••

See Philippe's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for AbolerIS Pharma's next move

Learn about Strategic plan

AbolerIS Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.